Experiments on animals (“in vivo” experiments) have long been the norm for learning about human health and disease, because testing on live animals enables researchers to investigate how chemicals, ...

Both the UK and US Governments have pledged to end research using animals, but is such a goal realistic? And how might it change medical research? Talha Burki reports.

I am living with ALS, or amyotrophic lateral sclerosis, often called Lou Gehrig’s disease. The average survival time after diagnosis is two to five years. I’m in year two.

FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods and artificial intelligence to determine drug safety and effectiveness.

Editor’s note: This article contains graphic descriptions of how animals are treated during testing. The skulls of living cats are drilled with holes to screw metal strainer posts into their heads, ...

On April 10, the US Food and Drug Administration announced it would phase out animal testing for certain drug studies. The agency published a roadmap that outlines a six-prong approach to reducing ...

Six-month-old Beagle puppies are put in jackets that inject them with cocaine and meth, causing them to vomit and foam at the mouth, as part of a drug testing study by the National Institutes of ...

Animal testing in Connecticut rakes in millions in federal dollars each year at colleges and universities but, the National Institutes of Health recently announced it is pivoting from using just ...

There’s a reason this law change has been labelled “sneaky”. While SIs are routinely used to make technical or administrative ...

While the use of animals to test the safety of cosmetic products in the U.S. is legal, a number of states have brought in laws to ban the practice. The Food and Drug Administration (FDA) notes that ...

April 10 (UPI) --The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and ...